Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.53 +0.15%
Financial Fact:
General and administrative: 997K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
General and administrative: 997K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q3 loss of ($0.32), $0.03 better than the analyst estimate of ($0.35).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Children's Place (PLCE) Misses Q2 EPS by 20c
- AutoZone beats profit view but misses on revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
